This Study Investigates β-hydroxy-β-methylbutyrate (HMB) and 2-hydroxybenzylamine (2-HOBA), When Administered Either Individually or in Combination Contributes to an Increased Quality of Health, Specifically Improving Muscular Strength and Cognitive Functioning in Adults Over the Age of 65.

Clinical trial NCT07419633 · RECRUITING

Trial details

NCT number: NCT07419633
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Muscle Cognitive Functioning Geriatric Ageing and Geriatric Health Ageing

Start date: 2026-03-06
Primary completion: 2027-02-05
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.